Sandra Lara

505 total citations
12 papers, 382 citations indexed

About

Sandra Lara is a scholar working on Immunology, Molecular Biology and Biomaterials. According to data from OpenAlex, Sandra Lara has authored 12 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 3 papers in Biomaterials. Recurrent topics in Sandra Lara's work include Advanced biosensing and bioanalysis techniques (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Immunotherapy and Immune Responses (3 papers). Sandra Lara is often cited by papers focused on Advanced biosensing and bioanalysis techniques (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Immunotherapy and Immune Responses (3 papers). Sandra Lara collaborates with scholars based in Sweden, Ireland and Slovakia. Sandra Lara's co-authors include André Perez‐Potti, Kenneth A. Dawson, Yan Yan, Ester Polo, Cristina Lo Giudice, Louise Rocks, Anna Salvati, David Garry, Delyan R. Hristov and Sandra Kleinau and has published in prestigious journals such as ACS Nano, The Journal of Immunology and International Journal of Molecular Sciences.

In The Last Decade

Sandra Lara

11 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Lara Sweden 8 182 178 158 81 47 12 382
Milagros Avila-Olias United Kingdom 6 199 1.1× 118 0.7× 153 1.0× 99 1.2× 54 1.1× 6 441
Patricia Renz Germany 7 187 1.0× 171 1.0× 122 0.8× 47 0.6× 59 1.3× 13 435
Francesca Giulimondi Italy 13 289 1.6× 309 1.7× 236 1.5× 61 0.8× 52 1.1× 21 561
Sylvie Lélu Norway 8 153 0.8× 205 1.2× 144 0.9× 125 1.5× 23 0.5× 9 520
Valentina Francia Netherlands 10 295 1.6× 392 2.2× 199 1.3× 125 1.5× 49 1.0× 11 718
Erica Quagliarini Italy 15 154 0.8× 196 1.1× 249 1.6× 61 0.8× 15 0.3× 31 434
Diego Estupiñán Germany 7 182 1.0× 132 0.7× 137 0.9× 97 1.2× 63 1.3× 11 433
Huajin Zhang China 6 198 1.1× 145 0.8× 159 1.0× 94 1.2× 26 0.6× 8 397
Jiao Qu China 10 127 0.7× 101 0.6× 202 1.3× 82 1.0× 21 0.4× 26 374
Zeinab Farhadi Sabet China 7 230 1.3× 172 1.0× 277 1.8× 116 1.4× 25 0.5× 8 481

Countries citing papers authored by Sandra Lara

Since Specialization
Citations

This map shows the geographic impact of Sandra Lara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Lara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Lara more than expected).

Fields of papers citing papers by Sandra Lara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Lara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Lara. The network helps show where Sandra Lara may publish in the future.

Co-authorship network of co-authors of Sandra Lara

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Lara. A scholar is included among the top collaborators of Sandra Lara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Lara. Sandra Lara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Nguyen, Oanh T. P., Sandra Lara, Giovanni Ferro, Matthias Peipp, & Sandra Kleinau. (2024). Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression. Frontiers in Immunology. 15. 1483617–1483617.
3.
Akula, Srinivas, Sandra Lara, Anna‐Karin Olsson, & Lars Hellman. (2022). Quantitative Analysis of the Transcriptome of Two Commonly Used Human Monocytic Cell Lines—THP-1 and Mono Mac 6—Reveals Their Arrest during Early Monocyte/Neutrophil Differentiation. International Journal of Molecular Sciences. 23(10). 5818–5818. 6 indexed citations
4.
Lara, Sandra, Srinivas Akula, Zhirong Fu, et al.. (2022). The Human Monocyte—A Circulating Sensor of Infection and a Potent and Rapid Inducer of Inflammation. International Journal of Molecular Sciences. 23(7). 3890–3890. 11 indexed citations
5.
Paivandy, Aida, Srinivas Akula, Sandra Lara, et al.. (2022). Quantitative In-Depth Transcriptome Analysis Implicates Peritoneal Macrophages as Important Players in the Complement and Coagulation Systems. International Journal of Molecular Sciences. 23(3). 1185–1185. 7 indexed citations
6.
Lara, Sandra, et al.. (2022). Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma. BMC Cancer. 22(1). 678–678. 8 indexed citations
7.
Lara, Sandra, et al.. (2021). Importance of antibody isotypes in antitumor immunity by monocytes and complement using human‐immune tumor models. European Journal of Immunology. 51(5). 1218–1233. 7 indexed citations
10.
Lara, Sandra & André Perez‐Potti. (2018). Applications of Nanomaterials for Immunosensing. Biosensors. 8(4). 104–104. 51 indexed citations
11.
Lara, Sandra, Ester Polo, David Garry, et al.. (2017). Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles. ACS Nano. 11(2). 1884–1893. 195 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026